Hoprin 25IU

Hoprin25IU Injection consists of Heparin 25000 IU/5mL and belongs to the class of medicines called anticoagulants. Heparin is an essential anticoagulant which is used in hospitals and clinical setups to help prevent and handle the formation and growth of blood clots. Hoprin 25IU can only be used under the supervision of qualified healthcare professionals and may become a part of anticoagulation protocols for patients that need medical management of thrombotic conditions.

Composition of Hoprin 25IU

Each 5 mL of Hoprin 25IU Injection consists of:

Heparin – 25,000 IU

The formulation should be given only according to the dosage and instructions prescribed by a qualified healthcare professional.

How Does Hoprin 25IU Work?

Heparin works by enhancing the activity of antithrombin, a naturally occurring protein that helps regulate the body’s blood-clotting process. This action reduces the activity of several clotting factors, particularly thrombin and factor Xa, thereby helping to prevent the formation and extension of blood clots.

Unlike medicines that dissolve an already established clot, heparin primarily works by reducing further clot formation and allowing the body’s natural processes to manage existing clots. The dose and treatment duration depend on the patient’s condition, clinical requirements, and response to treatment.

Uses of Hoprin 25IU Injection

Heparin injections may be used in various clinical situations where anticoagulation is required. Depending on the patient’s condition and established treatment protocols, heparin may be used for the prevention or treatment of venous thromboembolism and other thrombotic disorders. It may also be used in certain hospital procedures where preventing blood clot formation is clinically important.

The decision to administer Hoprin 25IU should always be made by a healthcare professional after evaluating the patient’s medical history, current condition, bleeding risk, and other relevant factors.

Administration and Precautions

Hoprin 25IU is a prescription injectable medicine and should be administered by trained healthcare professionals. The prescribed dose should not be changed without medical advice. Patients receiving heparin may require appropriate laboratory monitoring, depending on the indication and treatment regimen.

Because heparin affects blood clotting, bleeding is an important potential adverse effect. Healthcare professionals should exercise particular caution in patients with active bleeding, bleeding disorders, recent surgery, or other conditions associated with increased bleeding risk. Heparin-induced thrombocytopenia is another important potential complication that requires medical attention.

Patients should inform their healthcare provider about all medicines they are taking, particularly other anticoagulants, antiplatelet medicines, or medicines that may increase bleeding risk.

Why Choose Diya Healthcare?

Diya Healthcare Pvt. Ltd. focuses on pharmaceutical manufacturing, marketing, and distribution, with a portfolio covering multiple therapeutic categories and dosage forms. The company states that its products are manufactured under strict quality-control systems and WHO-GMP standards.

Hoprin 25IU, containing Heparin 25,000 IU/5 mL, is positioned within the company’s critical-care and injectable portfolio, supporting the requirements of hospitals and healthcare professionals.